Aug 12, 2019:
Two experimental drugs have shown to be effective in the treatment of the ebola virus in the Democratic Republic of the Congo. The two drugs, both monoclonal antibodies, help the immune system fight off infection.
One drug, REGN-EB3, is made by Regeneron. The other drug, mAb114 (monoclonal antibody 114), was developed in a joint effort by the National Institute of Allergy and Infectious Diseases (NIAID) (an institute within the National Institutes of Health (NIH)) and scientists in Africa.
Source:
Harris, Richard. (August 12, 2019). "2 Experimental Ebola Drugs Saved Lives In Congo Outbreak". NPR. Retrieved 2019-08-25.
Update on Ebola drug trial: two strong performers identified | WHO
More: